SEARCH HEALTH CONDITIONS BY ALPHABETS
Hypophosphatasia
Medications for Hypophosphatasia
About Hypophosphatasia: Hypophosphatasia is a rare hereditary illness that causes elevated levels of alkaline phosphatase enzymes as a result of mutations of tissue nonspecific alkaline phosphatase (TNSALP) gene. Indicators of hypophosphatasia are highly variable and therefore are dependent of their clinical form.
Drugs Used in the Treatment of Hypophosphatasia
This listing of medications have been utilized at the treating this illness, or in some way associated with.
Medication title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
Strensiq | Rx | N | Insert inspection | 0.0 | |||
Generic title: asfotase Al-fa systemic Drug class: mixed metabolic representatives For users: dose, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
asfotase Al-fa | Rx | N | Insert inspection | 0.0 | |||
Generic title: asfotase Al-fa systemic Brand title: Strensiq Drug class: mixed metabolic representatives For users: dosage, For professionals: az Drug Truth, AHFS DI Monograph | |||||||
Legend
Rx | Prescription Only |
---|---|
OTC | On The Counter |
Rx/OTC | Prescription or Over the Counter |
Away Prizes | This medication may well not be approved by the FDA for the treatment of the illness. |
Pregnancy Category | |
---|---|
A | sufficient and well-controlled studies have failed to present a risk to the embryo within the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown an adverse effect on the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential gains. |
N | FDA have not classified this drug. |
Controlled Substances Act (CSA) Program | |
---|---|
N | isn`t subject to the Controlled Substances Act. |
1 | includes a higher potential for abuse. Has no accepted medical use in treatment in the USA. There`s a lack of accepted safety for use under medical supervision. |
2 | includes a higher potential for abuse. Has a currently accepted medical use in treatment in the USA or a currently accepted medical use with severe restrictions. Psychotherapy can cause acute emotional or physical dependence. |
3 | Has a potential for abuse less than those in programs 1 and 2 two. Has a currently accepted medical use in treatment in the USA. Psychotherapy can lead to moderate or low physical dependence or high psychological dependence. |
4 | includes a minimal potential for abuse in accordance with those in schedule 3. It`s a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | includes a minimal potential for abuse in accordance with those in schedule 4. Has a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence. |
Infection | |
---|---|
X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Janin
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always consult your healthcare provider to ensure the information displayed on these pages relates to your circumstances.
- Hydatid Disease
- Hymenolepiasis
- Hyperacousis
- Hyperacusis
- Hyperammonemia
- Hypercalcemia of Malignancy
- Hypercalciuria
- Hyperekplexia
- Hyperemesis Diet
- Hyperemesis Gravidarum with Metabolic Disturbance
- Hyperexplexia
- Hyperhomocysteinemia
- Hyperhomocystenemia
- Hyperimmunoglobulin D Periodic Fever Syndrome
- Hyperimmunoglobulin D Syndrome
- Hyperkalemic Periodic Paralysis
- Hyperkinetic Syndrome of Childhood
- Hyperlipoproteinemia
- Hyperlipoproteinemia Type IIa, Elevated LDL
- Hyperlipoproteinemia Type IIb, Elevated LDL VLDL
- Hyperlipoproteinemia Type III, Elevated Beta-VLDL IDL
- Hyperlipoproteinemia Type IV, Elevated VLDL
- Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL
- Hyperlipoproteinemia, Fredrickson Type IIa
- Hyperlipoproteinemia, Fredrickson Type IIb
- Hyperlipoproteinemia, Fredrickson Type III
- Hyperlipoproteinemia, Fredrickson Type IV
- Hyperlipoproteinemia, Fredrickson Type V
- Hyperparathyroidism Secondary to Renal Impairment
- Hyperphosphatemia
- Hyperphosphatemia of Renal Failure
- Hyperprolactinemia
- Hypersecretory Conditions
- Hypersensitivity Vasculitis
- Hypersexuality State
- Hypersomnia
- Hypertensive Congestive Heart Failure
- Hypertensive Encephalopathy
- Hypertensive Heart Disease
- Hypertensive Heart with CHF and Renal Disease
- Hypertensive Heart Without CHF and Renal Disease
- Hypertensive Renal Disease
- Hypertensive Retinopathy
- Hypertensive Urgency
- Hyperuricemia Secondary to Chemotherapy
- Hypervitaminosis A
- Hypervitaminosis D
- Hypodermoclysis
- Hypoestrogenism
- Hypokalemic Periodic Paralysis
- Hypoparathyroidism
- Hypophosphatasia
- Hypoproteinemia
- Hypoprothrombinemia
- Hypoprothrombinemia, Anticoagulant Induced
- Hypoprothrombinemia, Not Associated with Anticoagulant Therapy
- Hypoprothrombinemia, Prophylaxis
- Hypotension Secondary to Hemodialysis
- Hypotrichosis of Eyelashes
- Hypoventilation
- Hypovolemia
- Hysterosalpingography
Popular Categories
Health Condition
- Hydatid Disease
- Hymenolepiasis
- Hyperacousis
- Hyperacusis
- Hyperammonemia
- Hypercalcemia of Malignancy
- Hypercalciuria
- Hyperekplexia
- Hyperemesis Diet
- Hyperemesis Gravidarum with Metabolic Disturbance
- Hyperexplexia
- Hyperhomocysteinemia
- Hyperhomocystenemia
- Hyperimmunoglobulin D Periodic Fever Syndrome
- Hyperimmunoglobulin D Syndrome
- Hyperkalemic Periodic Paralysis
- Hyperkinetic Syndrome of Childhood
- Hyperlipoproteinemia
- Hyperlipoproteinemia Type IIa, Elevated LDL
- Hyperlipoproteinemia Type IIb, Elevated LDL VLDL
- Hyperlipoproteinemia Type III, Elevated Beta-VLDL IDL
- Hyperlipoproteinemia Type IV, Elevated VLDL
- Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL
- Hyperlipoproteinemia, Fredrickson Type IIa
- Hyperlipoproteinemia, Fredrickson Type IIb
- Hyperlipoproteinemia, Fredrickson Type III
- Hyperlipoproteinemia, Fredrickson Type IV
- Hyperlipoproteinemia, Fredrickson Type V
- Hyperparathyroidism Secondary to Renal Impairment
- Hyperphosphatemia
- Hyperphosphatemia of Renal Failure
- Hyperprolactinemia
- Hypersecretory Conditions
- Hypersensitivity Vasculitis
- Hypersexuality State
- Hypersomnia
- Hypertensive Congestive Heart Failure
- Hypertensive Encephalopathy
- Hypertensive Heart Disease
- Hypertensive Heart with CHF and Renal Disease
- Hypertensive Heart Without CHF and Renal Disease
- Hypertensive Renal Disease
- Hypertensive Retinopathy
- Hypertensive Urgency
- Hyperuricemia Secondary to Chemotherapy
- Hypervitaminosis A
- Hypervitaminosis D
- Hypodermoclysis
- Hypoestrogenism
- Hypokalemic Periodic Paralysis
- Hypoparathyroidism
- Hypophosphatasia
- Hypoproteinemia
- Hypoprothrombinemia
- Hypoprothrombinemia, Anticoagulant Induced
- Hypoprothrombinemia, Not Associated with Anticoagulant Therapy
- Hypoprothrombinemia, Prophylaxis
- Hypotension Secondary to Hemodialysis
- Hypotrichosis of Eyelashes
- Hypoventilation
- Hypovolemia
- Hysterosalpingography